Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease

A legfontosabb adatok

Ki végzi
University of Texas Southwestern Medical Center
Hol
Atlanta, Boston, Chicago, Cincinnati, Columbus, Dallas, Fort Worth, Houston, Kansas City, Little Rock, Mount Pleasant, Oklahoma City, Philadelphia és St. Petersburg (Egyesült Államok)Mind a 14 helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
115 fő vett részt
Kezdés
2020. dec. 22.
Várható befejezés
2027. márc.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Blood draw (Visit 1)
  • Blood draw (Visits 2 and 3)
A regiszteradat frissítve
2026. június 8.

Ki vehet részt

Életkor
8 év – 21 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 18 feltétel megnézéseKevesebb

Ki vehet részt

  • Ages 8 to ≤ 21 years
  • Participant must be able to speak and understand English
  • Be willing to participate and able to comply with the study protocol
  • For participants with PE: Children with acute, radiologically confirmed pulmonary embolism (PE) with our without DVT
  • For control group: Cohort 1: Children who are prescribed physical activity restrictions for 2 up to 12 weeks following any minor outpatient surgery or, minor injury (surgery or injury is referred to as "diagnosis" hereafter) Cohort 2: Children who are not prescribed physical activity restrictions and are otherwise considered to be healthy

Ki nem vehet részt

  • Frequent severe exacerbations of asthma defined by two or more bursts of systemic glucocorticoids (more than three days each) in the previous year or at least one hospitalization, intensive care unit stay or mechanical ventilation in the previous year. Patients should also be excluded if there are daily symptoms of asthma requiring daily use of short-acting bronchodilators such as albuterol or levalbuterol administration. The use of controller medications such as daily inhaled corticosteroids for mild persistent asthma is not exclusionary
  • Prior history of DVT or PE (upper extremity, cerebral sinus venous thrombosis and abdominal thromboses encountered as a neonate are not exclusion criteria)
  • Congenital heart disease with abnormal pulmonary circulation or with in-situ pulmonary artery thrombosis
  • Chronic kidney disease
  • Chronic inflammatory or an autoimmune disorder (such as systemic lupus erythematosus, juvenile rheumatoid disorder, inflammatory bowel disease, and sickle cell disease)
  • A metabolic or endocrinological disorder such as diabetes mellitus or thyroid disorder
  • History of or active cancer
  • Has any other medical condition, which in the opinion of the investigator may potentially compromise the safety or compliance of the patient or may preclude the patient's successful completion of the clinical study; Additional exclusion criteria for participants with PE:
  • Pregnant
  • Musculoskeletal limitations to exercise expected to be present uptil 4 months post-diagnosis
  • Weight ≥ 300 lbs
  • Contraindications to magnetic resonance imaging
  • Lack of anticoagulant treatment for the acute VTE due to contraindications

Helyszínek itt: Egyesült Államok

  • Emory University / Children's Heathcare AtlantaAtlanta, Egyesült Államok
  • Boston Children's HospitalBoston, Egyesült Államok
  • Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Egyesült Államok
  • Cincinnati Childrens HospitalCincinnati, Egyesült Államok
  • Nationwide Children's HospitalColumbus, Egyesült Államok
  • UT Southwestern Medical Center / Children's Medical CenterDallas, Egyesült Államok
  • Cook Childrens Medical CenterFort Worth, Egyesült Államok
  • Texas Children's HospitalHouston, Egyesült Államok
  • Childrens Mercy HospitalKansas City, Egyesült Államok
  • Arkansas Childrens Research Institute (ACRI)Little Rock, Egyesült Államok
  • Central Michigan UniversityMount Pleasant, Egyesült Államok
  • University of Oklahoma Health Sciences CenterOklahoma City, Egyesült Államok
  • Children's Hospital of PhiladelphiaPhiladelphia, Egyesült Államok
  • Johns Hopkins All Childrens HospitalSt. Petersburg, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a multi-center prospective cohort study of patients with first-episode deep venous thrombosis and pulmonary embolism.

A vizsgálat 2 csoportja

  • Participants with Pulmonary Embolism

    The target accrual is based on the primary endpoint (exercise intolerance and dyspnea on exertion). To achieve adequate power and precision in the primary analysis, the target enrollment is 80 children. Both males and females of all races and ethnic groups are eligible for this study.

    Kezelés: Blood draw (Visit 1) és Blood draw (Visits 2 and 3)

  • Control Group

    A positive control group that has not had pulmonary embolism (PE) but is prescribed physical activity restrictions expected to produce a similar deconditioning effect as patients with PE will be enrolled from UT Southwestern only (cohort 1) or children who are no prescribed physical activity restrictions and are otherwise considered healthy (cohort 2). The target accrual of the positive control group is based on feasibility and availability of funds and will be limited to 25 controls.

    Kezelés: Blood draw (Visits 2 and 3)

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
FUVID Study: A Multi-center, Prospective Study Evaluating Exercise Intolerance and Dyspnea on Exertion in Patients Following First-episode Deep Venous Thrombosis and Pulmonary Embolism
A regiszteradat frissítve
2026. június 8.